Skip to main content

Congestive Heart Failure News (Page 6)

New Heart Implant Monitors, Treats -- and Then Dissolves Away

FRIDAY, July 7, 2023 – An experimental implant now under development could serve as a temporary monitor and pacemaker for ailing heart patients – then dissolve away when it’s no longer needed. The s...

Metabolic Surgery Cuts Cardiovascular Events for Obesity, Sleep Apnea

THURSDAY, July 6, 2023 – Metabolic surgery is associated with a lower risk for major adverse cardiovascular events (MACE) in patients with obstructive sleep apnea (OSA) and obesity, according to a...

FDA Approves Entresto (sacubitril/valsartan) for Heart Failure

July 7, 2015 – The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of...

FDA Medwatch Alert: Dobutamine Injection (250mg/20mL)/Hospira: Recall - Visible Particulates

ISSUE: Hospira, Inc. issued a nationwide recall to the user level for one lot of Dobutamine Injection, USP, 250 mg, 20 mL, Single-dose fliptop vial, (NDC 0409-2344-02), Lot 27-352-DK. (NDC and lot...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Left Ventricular Dysfunction, Cardiovascular Conditions and Disorders

Related drug support groups

lisinopril, metoprolol, warfarin, Coumadin, spironolactone, triamcinolone, carvedilol, Metoprolol Succinate ER, diltiazem, view more... Lasix, furosemide, bisoprolol, valsartan, Entresto, Farxiga, ramipril, Jardiance, digoxin, prazosin, Diovan, nitroglycerin, Coreg